Mahy Mary, Warner-Smith Matthew, Stanecki Karen A, Ghys Peter D
UNAIDS, Geneva, Switzerland.
J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S152-9. doi: 10.1097/QAI.0b013e3181baf128.
In the Declaration of Commitment of the 2001 United Nations General Assembly Special Session on AIDS, all Member States agreed to a series of actions to address HIV. This article examines the availability of data to measure progress toward reducing HIV incidence and AIDS mortality and discusses the extent to which changes can be attributed to programs.
Lacking a method to directly measure HIV incidence, trends in HIV prevalence among 15-year to 24-year olds and groups with high-risk behaviors are used as a proxy measure for incidence trends among adults in generalized and concentrated/low-level epidemics, respectively. Although there is limited empirical data on trends in new infections among children, progress in the treatment area is tracked through indicators for the percentage of people who remain on antiretroviral treatment 12 months after initiation and the coverage of antiretroviral treatment. Successive iterations of epidemiological models using surveillance data from pregnant women and groups with high-risk behavior and data from national household surveys, demographic data and epidemiological assumptions have produced increasingly robust estimates of HIV prevalence, incidence and mortality.
Globally, incidence has decreased among adults (accompanied by evidence of changes in behavior in several countries) and children over the past decade. The decline in AIDS mortality is more recent. On the basis of the underlying logical framework and mathematical models, it is concluded that programs have contributed to a reduction in HIV incidence and AIDS mortality.
More data are needed to reliably inform trends in HIV incidence and AIDS mortality in many countries to allow an assessment of progress against national and global targets. In addition, impact evaluation studies are needed to assess the relationship between changes in incidence and mortality and the HIV response and to determine the extent to which these changes can be attributed to specific programmatic interventions.
在2001年联合国大会艾滋病问题特别会议的《承诺宣言》中,所有会员国商定了一系列应对艾滋病毒的行动。本文研究了用于衡量在降低艾滋病毒发病率和艾滋病死亡率方面进展情况的数据的可得性,并讨论了这些变化可归因于各项计划的程度。
由于缺乏直接测量艾滋病毒发病率的方法,15至24岁人群以及具有高危行为群体中的艾滋病毒流行趋势,分别被用作广义流行和集中/低水平流行中成年人发病率趋势的替代指标。虽然关于儿童新感染趋势的实证数据有限,但通过开始接受抗逆转录病毒治疗12个月后仍继续治疗的人数百分比以及抗逆转录病毒治疗覆盖率等指标来跟踪治疗领域的进展。利用孕妇和高危行为群体的监测数据、全国家庭调查数据、人口数据以及流行病学假设,对流行病学模型进行连续迭代,得出了对艾滋病毒流行率、发病率和死亡率越来越可靠的估计。
在过去十年中,全球成年人(同时有几个国家行为变化的证据)和儿童中的发病率有所下降。艾滋病死亡率的下降则较为新近。根据基本的逻辑框架和数学模型得出结论,各项计划有助于降低艾滋病毒发病率和艾滋病死亡率。
许多国家需要更多数据,以便可靠地了解艾滋病毒发病率和艾滋病死亡率的趋势,从而能够评估在实现国家和全球目标方面的进展。此外,需要进行影响评估研究,以评估发病率和死亡率变化与艾滋病毒应对措施之间的关系,并确定这些变化可归因于具体计划干预措施的程度。